Farestos

ACTIVE HALF-LIFE 6-7 Days
CLASSIFICATION Selective Estrogen Receptor Modulator
DOSAGE 10-40 mg/day
ACNE No
WATER RETENTION No
HBR No
HEPATOTOXICITY No
AROMATIZATION No
MANUFACTURER Pharmacom Labs - US
LAB TEST See Document
WAREHOUSE USA Warehouse 4
SUBSTANCE Toremifene Citrate

Introducing Farestos, a cutting-edge alternative to Clomid that embodies all its remarkable benefits!

Toremifene Citrate is a selective estrogen receptor modulator (SERM) derived from triphenylethylene. Patented and approved in Europe in the mid-1990s, it is used to treat metastatic ER+ breast cancer in postmenopausal women.

In the world of bodybuilding, men turn to Toremifene Citrate as an essential post-cycle therapy (PCT) tool. It effectively counters the negative effects of increased estradiol that can arise from various androgen cycles, helping to restore natural testosterone levels and prevent estrogen-related issues like gynecomastia.

It's crucial to understand that Toremifene Citrate operates as a true estrogen blocker, distinguishing it from aromatase inhibitors. It blocks estradiol from exerting its effects by binding to its receptor sites more effectively than estradiol itself. By occupying these sites, Toremifene prevents estradiol from attaching and activating them.

Importantly, Toremifene does not lower overall estradiol levels in the bloodstream; it simply inhibits its action in specific tissues. This is the key difference from aromatase inhibitors, which reduce total estradiol levels by targeting the aromatase enzyme responsible for converting androgens to estradiol.

Chemically similar to tamoxifen, Toremifene is a next-generation medication that typically presents fewer toxic side effects.

However, Toremifene does have some drawbacks. Notably, it can negatively affect SHBG (Sex Hormone Binding Globulin) levels. Clinical studies indicate that while it stimulates natural testosterone production, it may also elevate SHBG in the blood, potentially reducing cycle efficiency when used to manage gynecomastia symptoms.

When it comes to HPTA restoration and endogenous testosterone production in males, Toremifene is less effective than tamoxifen at comparable doses. Research shows that a daily 60mg dose of Toremifene resulted in a 42% increase in testosterone levels, which, while notable, is lower than the 71% increase seen with a standard 20mg daily dose of tamoxifen in the same study.

To achieve optimal testosterone production, it is recommended to increase the Toremifene dosage up to 120mg per day, starting with this amount for the first week of PCT, reducing to 100mg in the second week, and then tapering to 60mg per day for the final 3-4 weeks. Individual dosage adjustments should be based on personal blood work results.

There are no special requirements for taking Toremifene; it can be consumed at any time?before, during, or after meals, whether in the morning or evening. Due to its half-life of approximately 5 days, there?s no need for split dosing, ensuring stable blood levels over a 24-hour period or longer.

The listed price is for one blister containing 50 pills. If you order a single blister, it will be shipped without the original packaging. To receive the original box, please order two blisters (100 pills).